Dr. Michael A. Scutella, MD
OB-GYN (Obstetrics & Gynecology) (Obstetrics & Gynecology Physician)
- Medicare participating
At a glance
- Medical school
- Hahnemann University College of Medicine (1984)
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 492
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1984Medical school: Hahnemann University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Obstetrics & Gynecology Physician primary
PA license MD038903E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: OB-GYN (Obstetrics & Gynecology) per capita by county →
Where they work
Hospitals
- UPMC Hamot Erie, PA
- Saint Vincent Hospital Erie, PA
- Lecom Health Corry Memorial Hospital Corry, PA
Medical groups
- Ob-Gyn Associates of Erie, PC (60 clinicians)
- Corry Memorial Hospital Association (30 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 492
- Services billed
- 3,160
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 1,980 | 23 |
| Dxa bone density measurement of hip, pelvis, spine | 260 | 260 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 191 | 191 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 168 | 168 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 84 | 71 |
| Established patient office or other outpatient visit, 10-19 minutes | 53 | 52 |
| Injection of drug or substance under skin or into muscle | 41 | 27 |
| Established patient office or other outpatient visit, 20-29 minutes | 31 | 20 |
| Established patient office or other outpatient visit, 30-39 minutes | 15 | 14 |
| Limited ultrasound scan of pelvis | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Estradiol Other prescribers in Erie, PA | 130 |
| Alendronate Sodium Other prescribers in Erie, PA | 67 |
| Medroxyprogesterone Acetate Other prescribers in Erie, PA | 48 |
| Premarin (estrogens, conjugated) Other prescribers in Erie, PA | 44 |
| Clotrimazole-Betamethasone (clotrimazole/betamethasone dip) Other prescribers in Erie, PA | 35 |
| Prempro (estrogen,con/m-progest acet) | 29 |
| Risedronate Sodium Other prescribers in Erie, PA | 29 |
| Clobetasol Propionate Other prescribers in Erie, PA | 28 |
| Fluconazole Other prescribers in Erie, PA | 18 |
| Metronidazole Other prescribers in Erie, PA | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 7 payments worth $205 in total to this clinician.
| Caldera Medical, Inc | $88.63 |
|---|---|
| Pfizer Inc. | $27.78 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.62 |
| Exact Sciences Corporation | $18.85 |
| AbbVie Inc. | $17.44 |
| Corcept Therapeutics | $16.56 |
| Amgen Inc. | $14.24 |
| Food and Beverage | $205 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $61,291 in research payments for these studies, mostly to the institutions running them.
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma America, Inc. · Recruiting · NCT05862272 - A master protocol to investigate the efficacy and safety of orforglipron tablet once daily compared with placebo in female participants with stress urinary incontinence who have obesity or overweight (restrain-sui) ; …
Eli Lilly and Company - Study name not reported
Organon Llc - LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Exeltis, USA Inc. · Active, not recruiting · NCT05303636
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.